Nachrichten zur Quest Diagnostics Aktie

Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript

…

Quest Diagnostics (DGX) Q4 Revenues Top, Gross Margin Down

Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the fourth quarter of 2023.…

Quest Diagnostics (DGX) Q4 Earnings and Revenues Beat Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 0.47% and 1.80%, respectively, for the quarter ended December 2023. Do…

Quest Diagnostics (DGX) Advances in Cancer Research With New Deal

Quest Diagnostics (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.…

Quest Diagnostics (DGX) and Fitbit Team Up for New Pilot Study

Quest Diagnostics (DGX) partners with Fitbit to study the potential of wearable devices to improve metabolic health.…

3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024

Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide…

Quest Diagnostics (DGX) to Post Q4 Earnings: Whats in Store?

Quest Diagnostics (DGX) fourth-quarter 2023 results are likely to reflect the robust strength of its base business.…

Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics

Quest Diagnostics (DGX) new partnership is likely to leverage its oncology expertise and national scale.…

Quest Diagnostics (DGX) to Boost Lab Services With New Buyout

Quest Diagnostics (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.…

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.…

Quest Diagnostics (DGX) Unveils the 88-Compound NPS Test Panel

Quest Diagnostics (DGX) launches the new 88-Compound NPS test panel to address the changing drug epidemic.…

Quest Diagnostics (DGX) Haystack Oncology Inks New Deal

Quest Diagnostics (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.…

Quest Diagnostics (DGX) & CDC to Assess Hepatitis C Burden

Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.…

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business.…

Quest Diagnostics (DGX) New Pact to Scale Precision Medicine

Quest Diagnostics (DGX) will supply next-generation sequencing and enhanced RNA extraction services for Sciphers PrismRA test through a new collaboration.…

Quest Diagnostics (DGX) New Pact to Advance Cancer Screening

Quest Diagnostics (DGX) latest partnership will increase the likelihood that Americans will eventually have an easy, reliable and accessible way…

Quest Diagnostics wird eine unveränderte Dividende auszahlen

Der amerikanische Medizintechniker Quest Diagnostics Inc. (ISIN: US74834L1008, NYSE: DGX) zahlt am 31. Januar 2024 eine vierteljährliche Dividende in Höhe…

Quest Diagnostics (DGX) Introduces Mobile Phlebotomy Service

Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostics laboratory testing with the launch of…

Analyst Report: Quest Diagnostics, Inc.

…

Asia Cervical Cancer Screening Markets, 2023-2028 with AstraZeneca, Hologic, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health Dominating

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends,…

Quest Diagnostics setzt Maßstäbe im bärischen Börsenumfeld

Anzeige / WerbungQuest Diagnostics setzt Maßstäbe im bärischen BörsenumfeldWährend die Aktienmärkte aktuell allgemein auf Tauchstation gehen und ihrem Bärenmarkt folgen,…

Quest Diagnostics inks licensing deal for Alzheimer’s testing

…

Quest Diagnostics Inc. (DGX) Q3 2023 Earnings Call Transcript

…

: Quest Diagnostics profit falls 12%, but beats estimate

Quest Diagnostics Inc. DGX said Tuesday its third-quarter profit dropped by 12.2% to $225 million, or $1.96 a share, from…

Quest Diagnostics (DGX) Tops Q3 Earnings, Gross Margin Dips

Quest Diagnostics (DGX) base business growth reflects the companys ongoing efforts to partner with health plans, hospitals and physicians amid…

Quest Diagnostics (DGX) to Post Q3 Earnings: Whats in Store?

Quest Diagnostics (DGX) third-quarter 2023 results are likely to reflect continued strength in the base business.…

Quest Diagnostics (DGX) Gains From New Alliances Amid FX Woes

Quest Diagnostics (DGX) recent acquisition of New York-Presbyterians outreach assets adds to volume growth within Physician Lab Services.…

Quest Diagnostics (DGX) Base Volume Aids Amid Low COVID Tests

Quest Diagnostics (DGX) continues to witness growth momentum in the cardiometabolic, endocrinology, infectious disease and carrier and prenatal genetic screening…

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 14, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the worlds leading provider of diagnostic information services, today…

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions....…

Quest Diagnostics Unveils Consumer-Initiated Alzheimers Test >DGX

Quest Diagnostics Unveils Consumer-Initiated Alzheimer's Test >DGX...…

Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease

Quest Diagnostics Inc. DGX said Monday it has brought the first blood-based biomarker test to assess the risk of developing…

Quest Diagnostics brings first blood-based test for Alzheimer’s disease risk assessment

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Quest Diagnostics (DGX) Q2 Earnings Beat Estimates, FY View Up

Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023....…

Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.14% and 4.22%, respectively, for the quarter ended June 2023. Do…

Quest Diagnostics beats profit estimates as routine testing picks up

...July 26 (Reuters) - Laboratory operator Quest Diagnostics Inc beat......…

Quest Diagnostics Q2 Profit Increases, beats estimates

WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) released a profit for its second quarter that increased from the same period last…

Quest Diagnostics Cuts Profit Outlook Amid Higher Labor Costs

Quest Diagnostics Cuts Profit Outlook Amid Higher Labor Costs...…

Quest Diagnostics 2Q Revenue Falls on Lower Productivity Effects

Quest Diagnostics 2Q Revenue Falls on Lower Productivity Effects...…

Form 8-K QUEST DIAGNOSTICS INC For: Jul 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

Second quarter revenues of $2.34 billion, down 4.7% from 2022 Second quarter reported diluted earnings per share ("EPS") of $2.05,…

Quest Diagnostics: Q4HE Collaborates With Western University of Health Sciences To Support Biopsies Save Lives

NORTHAMPTON, MA / ACCESSWIRE / July 20, 2023 / Quest Diagnostics, through the Quest for Health Equity (Q4HE) initiative, has…

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions....…

Quest Diagnostics (DGX) Brings New Test for Prostate Cancer

Quest Diagnostics (DGX) collaborates with Envision Sciences to bring a novel prosate cancer biomarker test....…

Quest Diagnostics Employees Support Healthy NewsWorks Student Journalists

NORTHAMPTON, MA / ACCESSWIRE / July 13, 2023 / On May 23, several Quest Diagnostics employees volunteered at the Healthy…

XFRA : DIVIDEND/INTEREST INFORMATION - 10.07.2023 - US74834L1008

Das Instrument QDI US74834L1008 QUEST DIAGNOSTICS DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 10.07.2023 The instrument QDI US74834L1008 QUEST DIAGNOSTICS…

Quest Diagnostics (DGX) Presents New Data on Disease Testing

Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative…

Quest Diagnostics: Inclusion in Action: Clifton and West Hills Labs

NORTHAMPTON, MA / ACCESSWIRE / June 27, 2023 / Quest DiagnosticsQuest proudly fosters an inclusive workplace where all of our…

Quest Diagnostics Completes Acquisition Of Haystack Oncology

WASHINGTON (dpa-AFX) - Quest Diagnostics Inc. (DGX), the nations leading provider of diagnostic information services, on Wednesday announced that it…

Quest Diagnostics To Acquire Haystack Oncology

WASHINGTON (dpa-AFX) - Quest Diagnostics Inc. (DGX), a US-based diagnostic laboratory, on Wednesday announced its agreement to acquire Haystack Oncology…